Total planned funding: $548,922,327
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Mozambique | $108,782,454 |
Zambia | $78,882,377 |
Nigeria | $72,130,444 |
South Africa | $32,669,097 |
Kenya | $30,317,923 |
Tanzania | $29,413,822 |
Vietnam | $19,709,831 |
Burundi | $18,526,476 |
Rwanda | $16,736,398 |
India | $15,203,182 |
Haiti | $14,536,495 |
Indonesia | $13,596,623 |
Cambodia | $11,975,000 |
Côte d'Ivoire | $10,316,632 |
Zimbabwe | $9,902,898 |
Asia Regional Program | $7,127,614 |
South Sudan | $6,271,024 |
Papua New Guinea | $6,195,286 |
Ethiopia | $6,007,247 |
Uganda | $5,807,847 |
Malawi | $5,225,205 |
Caribbean Region | $5,044,985 |
Democratic Republic of the Congo | $4,690,975 |
Angola | $4,689,597 |
Botswana | $3,740,003 |
Eswatini | $2,642,089 |
China | $2,350,000 |
Central America Region | $2,283,457 |
Dominican Republic | $1,668,747 |
Ghana | $1,290,000 |
Thailand | $478,599 |
Cameroon | $360,000 |
Central Asia Region | $350,000 |
Organizational Types
NGO | $533,600,890 |
Implementing Agency | $15,321,437 |
Program Areas
Prevention | $149,917,598 |
Treatment | $144,487,010 |
Care | $144,329,911 |
Testing | $60,331,880 |
Governance and Systems | $49,855,928 |
Budget Codes
HTXS: Treatment: Adult Treatment | $128,368,907 |
HVOP: Sexual Prevention: Other Sexual Prevention | $81,765,462 |
HKID: Care: Orphans and Vulnerable Children | $67,031,164 |
HVCT: Testing: HIV Testing and Counseling | $60,331,880 |
HBHC: Care: Adult Care and Support | $52,847,212 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $33,085,643 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $21,472,677 |
HVSI: Strategic Information | $19,468,827 |
HLAB: Laboratory Infrastructure | $16,391,438 |
OHSS: Health Systems Strengthening | $13,995,663 |
HVTB: Care: TB/HIV | $13,960,098 |
PDTX: Treatment: Pediatric Treatment | $12,694,819 |
PDCS: Care: Pediatric Care and Support | $10,491,437 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $9,395,875 |
HTXD: Treatment: ARV Drugs | $3,423,284 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $3,125,328 |
HMIN: Biomedical Prevention: Injection Safety | $557,684 |
HMBL: Biomedical Prevention: Blood Safety | $514,929 |